HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Net Equity Issued and Repurchased (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Net Equity Issued and Repurchased came in at $614.9 million in Q2 2021, up 253990.91% quarter-over-quarter from $242000.0 in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Net Equity Issued and Repurchased (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $614.9 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $614.9 million in Q2 2021; TTM through Jun 2021 was $614.9 million, a 405.84% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 99.75% from the prior year.
  • Net Equity Issued and Repurchased was $614.9 million for Q2 2021 at HUTCHMED (China), up from $242000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $614.9 million in Q2 2021 and troughed at $24000.0 in Q3 2018.
  • A 4-year average of $92.2 million and a median of $360000.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
  • Across the five-year window, Net Equity Issued and Repurchased sank 96.93% in 2019 and slumped 99.8% in 2021, its largest moves.
  • Over 4 years, Net Equity Issued and Repurchased stood at $3.1 million in 2018, then slumped by 96.93% to $96000.0 in 2019, then soared by 123171.88% to $118.3 million in 2020, then surged by 419.6% to $614.9 million in 2021.
  • The last three Net Equity Issued and Repurchased figures came in at $614.9 million (Q2 2021), $242000.0 (Q1 2021), and $118.3 million (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn -
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn 9.00 Mn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn 49.20 Mn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn -
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn -
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 614.90 Mn
Mar 31, 2021 242,000.00
Mar 31, 2020 118.34 Mn
Dec 31, 2019 96,000.00
Dec 31, 2018 3.12 Mn
Sep 30, 2018 24,000.00
Jun 30, 2018 466,000.00
Mar 31, 2018 254,000.00